This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kind Pharmaceutical. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Innovations of Xiangyun Tu in Pharmaceutical Chemistry
Introduction
Xiangyun Tu is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on indolizine derivatives. With a total of 4 patents to his name, Tu's innovations are paving the way for advancements in medical applications.
Latest Patents
Among his latest patents, Tu has developed indolizine derivatives and their application in medicine. This invention focuses on novel substituted indolizine derivatives, which can include isotopically labeled compounds, optical isomers, geometric isomers, tautomers, or mixtures of various isomers. Additionally, these compounds can be presented as pharmaceutically acceptable salts or prodrugs. The invention emphasizes the potential use of these compounds in medical applications, showcasing Tu's commitment to advancing healthcare solutions.
Career Highlights
Xiangyun Tu is currently associated with Kind Pharmaceutical, where he continues to innovate and contribute to the field. His work has garnered attention for its potential impact on medicine, particularly in developing new therapeutic agents.
Collaborations
Tu collaborates with talented individuals in his field, including Dong Liu and Dongdong Chen. These partnerships enhance the research and development process, leading to more robust innovations.
Conclusion
Xiangyun Tu's contributions to pharmaceutical chemistry through his patents on indolizine derivatives highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile